Variant report
Variant | esv2545701 |
---|---|
Chromosome Location | chr4:84767595-84769012 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:84767839..84770555-chr4:84773187..84775234,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs551247417 | chr4:84767829-84767830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150092376 | chr4:84767839-84767840 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138578784 | chr4:84767891-84767892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72935254 | chr4:84767892-84767893 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs146242439 | chr4:84767896-84767897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539641227 | chr4:84768015-84768016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377665446 | chr4:84768019-84768020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184733811 | chr4:84768139-84768140 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187205204 | chr4:84768146-84768147 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192171559 | chr4:84768186-84768187 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs183847974 | chr4:84768189-84768190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs138069920 | chr4:84768206-84768207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs188680006 | chr4:84768253-84768254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7663480 | chr4:84768278-84768279 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs533643888 | chr4:84768289-84768290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542891127 | chr4:84768291-84768292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs142572108 | chr4:84768329-84768330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72659233 | chr4:84768367-84768368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs550114763 | chr4:84768421-84768422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180809121 | chr4:84768478-84768479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532854558 | chr4:84768484-84768485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184531035 | chr4:84768485-84768486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566529805 | chr4:84768535-84768536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs72935257 | chr4:84768656-84768657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371456050 | chr4:84768700-84768701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs190594272 | chr4:84768705-84768706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115831885 | chr4:84768722-84768723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs13127644 | chr4:84768737-84768738 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs556554946 | chr4:84768744-84768745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs578058822 | chr4:84768783-84768784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs2129966 | chr4:84768801-84768802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs554370783 | chr4:84768804-84768805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572531883 | chr4:84768844-84768845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577349080 | chr4:84768857-84768858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs144112667 | chr4:84768864-84768865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554846404 | chr4:84768874-84768875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181930011 | chr4:84768907-84768908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs543822078 | chr4:84768952-84768953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186510000 | chr4:84768998-84768999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Prostate cancer | 16573809 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:84760000-84772400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr4:84767400-84767800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr4:84767600-84767800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:84767800-84770000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr4:84767800-84770200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
6 | chr4:84768000-84768200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr4:84768200-84771800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |